Mabpharm Limited's total assets for Q2 2025 were ¥1.07B, an increase of 5.08% from the previous quarter. HK:2181 total liabilities were ¥968.98M for the fiscal quarter, a 4.50% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.